Trillium Therapeutics
TRIL
#4821
Rank
S$2.48 B
Marketcap
S$23.65
Share price
0.00%
Change (1 day)
9,597.73%
Change (1 year)

Earnings for Trillium Therapeutics (TRIL)

Earnings in 2021 (TTM): S$80.59 Million

According to Trillium Therapeutics's latest financial reports the company's current earnings are S$0.23 Million. In 2020 the company made an earning of -S$78.82 Million a decrease over its 2019 earnings that were of -S$46.08 Million.

Earnings history for Trillium Therapeutics from 2005 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)S$80.59 M-202.26%
2020-S$78.82 Million71.05%
2019-S$46.08 Million51.44%
2018-S$30.43 Million-12.31%
2017-S$34.7 Million33.83%
2016-S$25.93 Million133.5%
2015-S$11.11 Million-14.44%
2014-S$12.98 Million165.45%
2013-S$4.89 Million249.29%
2012-S$1.4 Million-65.81%
2011-S$4.1 Million-26.08%
2010-S$5.54 Million12.35%
2009-S$4.93 Million-14.56%
2008-S$5.77 Million-10.01%
2007-S$6.42 Million-241.7%
2006S$4.52 M-268.2%
2005-S$2.69 Million